Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ULTRALIFE CORPULBI · Entity 6735 | Director | May 13, 2025 | May 14, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ULTRALIFE CORP
Report date May 13, 2025 · Filed May 14, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock; $.10 par valueSEC Table I · non-derivative | Direct | 85,000 |
Reported balance
After 2025-05-14 transaction · row 1
1 source rowRow 1 · 2025-05-14 · Purchase · Acquired 5,000 · Balance 85,000 F1: 5,000 shares purchased at an average cost of $5.4400 per share as follows: 2,995 shares purchased on May 13, 2025 at a cost of $5.4316 per share and 2,005 shares purchased on May 14, 2025 at a cost of $5.4525. |
Filing footnotes · ownership attribution and instrument terms
F1: 5,000 shares purchased at an average cost of $5.4400 per share as follows: 2,995 shares purchased on May 13, 2025 at a cost of $5.4316 per share and 2,005 shares purchased on May 14, 2025 at a cost of $5.4525.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2025 Filed May 14, 2025 20:54 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 5,000 | $5.44 | $27,200.00 |
DisclosureSEC source: 0001437749-25-016888 · rdgdoc.xml · nonDerivative · entry 1 Saeli Thomas Louis · CIK 0001490099 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,000 F1 · date: 5,000 shares purchased at an average cost of $5.4400 per share as follows: 2,995 shares purchased on May 13, 2025 at a cost of $5.4316 per share and 2,005 shares purchased on May 14, 2025 at a cost of $5.4525. Read SEC document |
| June 13, 2023 Filed Jun 14, 2023 15:50 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 4,554 | $4.97 | $22,644.77 |
DisclosureSEC source: 0001437749-23-017365 · rdgdoc.xml · nonDerivative · entry 1 Saeli Thomas Louis · CIK 0001490099 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 16:43 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 5,000 | $4.05 | $20,233.00 |
DisclosureSEC source: 0001437749-23-005742 · rdgdoc.xml · nonDerivative · entry 1 Saeli Thomas Louis · CIK 0001490099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,446 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.02 to $4.05. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported in this Form 4. Read SEC document |
| May 03, 2022 Filed May 3, 2022 18:51 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 10,000 | $4.89 | $48,850.00 |
DisclosureSEC source: 0001437749-22-010637 · rdgdoc.xml · nonDerivative · entry 1 Saeli Thomas Louis · CIK 0001490099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,446 F1 · price: The price reported is a weighted average price. The shares were purchased in two transactions of 5,000 shares each at $4.87 and $4.90. Read SEC document |
| November 14, 2018 Filed Nov 15, 2018 21:08 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 2,000 | $7.06 | $14,120.00 |
DisclosureSEC source: 0001437749-18-020942 · rdgdoc.xml · nonDerivative · entry 1 Saeli Thomas Louis · CIK 0001490099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,446 Read SEC document |
| May 11, 2018 Filed May 14, 2018 15:48 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 2,200 | $9.25 | $20,350.00 |
DisclosureSEC source: 0001437749-18-009707 · rdgdoc.xml · nonDerivative · entry 1 Saeli Thomas Louis · CIK 0001490099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,446 Read SEC document |
| May 24, 2017 Filed May 25, 2017 18:50 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 4,000 | $5.80 | $23,200.00 |
DisclosureSEC source: 0001437749-17-010083 · rdgdoc.xml · nonDerivative · entry 1 Saeli Thomas Louis · CIK 0001490099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,246 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.